DA Davidson Reiterates Buy Rating on Medifast (MED); Sees Upside Surprise Potential
Tweet Send to a Friend
DA Davidson analyst Linda Bolton Weiser reiterated a Buy rating and $250.00 price target on Medifast (NYSE: MED), saying they ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
